SAGABIO
Latest round
- Series A
Last raised
- Oct 2019
Total raised
- Undisclosed
Investors
- 1
About SAGABIO
Based in Shanghai, SAGABIO is a biotechnology company that engages in the R&D, and production, and sales of biological detection devices. It adopts the business model of instrument reagent linkage sales, which free-charge provides instruments to physical examination institutions, and hospitals, and sells the consumables regents. It established cooperation with the physical examination institution, Messinian Health. Its products include near-infrared fluorescent labeling chips, silica gel matrix membranes as protein chips, and biochip scanners. It adopts the silica gel matrix membrane as protein chips, which form multi-channel reaction sample holes, simplifying the chip reaction cleaning process, improving the detection sensitivity, and short the reaction times. The biochip scanners adopt point-by-point and line-by-line scanning, with high image resolution and no distortion.
Who invested in SAGABIO
1 investor across 1 round
See all investors in SAGABIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 21, 2019
Amount
Undisclosed
Investors
Questions about SAGABIO
Who invested in SAGABIO?
SAGABIO has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SAGABIO raised?
SAGABIO has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SAGABIO last raise money?
SAGABIO's most recent round on record is a Series A, in Oct 2019.
What does SAGABIO do?
Based in Shanghai, SAGABIO is a biotechnology company that engages in the R&D, and production, and sales of biological detection devices.
Where is SAGABIO headquartered?
SAGABIO is headquartered in Shanghai, China.
Which VCs invest in companies like SAGABIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at SAGABIO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SAGABIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.